Preserve-Transplant Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.

Also called NCT03102996

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 240 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03102996
Other papers using this trial's data
  • Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial Lancet (London, England), 2023-02-18 DOI, PubMed 36708734

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03102996. Randomized; single masking; primary purpose treatment. Start 2017-06-12 (actual); primary completion 2021-06-29 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Preserve-Transplant Study
Condition
Acidosis
Condition
Renal Insufficiency
Condition
Kidney Transplantation
Intervention (Drug)
Nephrotrans
Intervention (Other)
Placebo
Lead sponsor
University of Zurich (class: other)

Record details

Record id
cardio:ct-nct03102996
Content hash
2550f4d75004d8cd79a1a2c70456d92f87ea24a6ee180cbd397bd00eea9721d8